Privately held drug company Purdue Pharma said it would stop promoting the drug to doctors and cut its U.S. sales staff as it faces growing legal scrutiny amid an opioid-addiction crisis.
WSJ.com: US Business, Wall Street Journal: Business
Sat, 02/10/2018 - 5:06pm
Privately held drug company Purdue Pharma said it would stop promoting the drug to doctors and cut its U.S. sales staff as it faces growing legal scrutiny amid an opioid-addiction crisis.